543 related articles for article (PubMed ID: 9469411)
1. Cross-linking CD21/CD35 or CD19 increases both B7-1 and B7-2 expression on murine splenic B cells.
Kozono Y; Abe R; Kozono H; Kelly RG; Azuma T; Holers VM
J Immunol; 1998 Feb; 160(4):1565-72. PubMed ID: 9469411
[TBL] [Abstract][Full Text] [Related]
2. Complement opsonization is required for presentation of immune complexes by resting peripheral blood B cells.
Boackle SA; Morris MA; Holers VM; Karp DR
J Immunol; 1998 Dec; 161(12):6537-43. PubMed ID: 9862679
[TBL] [Abstract][Full Text] [Related]
3. Modulation of signaling via the B cell antigen receptor by CD21, the receptor for C3dg and EBV.
Luxembourg AT; Cooper NR
J Immunol; 1994 Nov; 153(10):4448-57. PubMed ID: 7525704
[TBL] [Abstract][Full Text] [Related]
4. Mouse complement receptors type 1 (CR1;CD35) and type 2 (CR2;CD21): expression on normal B cell subpopulations and decreased levels during the development of autoimmunity in MRL/lpr mice.
Takahashi K; Kozono Y; Waldschmidt TJ; Berthiaume D; Quigg RJ; Baron A; Holers VM
J Immunol; 1997 Aug; 159(3):1557-69. PubMed ID: 9233655
[TBL] [Abstract][Full Text] [Related]
5. CD21/CD35 in B cell activation.
Carroll MC
Semin Immunol; 1998 Aug; 10(4):279-86. PubMed ID: 9695184
[TBL] [Abstract][Full Text] [Related]
6. Regulation of B lymphocyte activation by complement C3 and the B cell coreceptor complex.
Rickert RC
Curr Opin Immunol; 2005 Jun; 17(3):237-43. PubMed ID: 15886112
[TBL] [Abstract][Full Text] [Related]
7. A minor population of splenic dendritic cells expressing CD19 mediates IDO-dependent T cell suppression via type I IFN signaling following B7 ligation.
Baban B; Hansen AM; Chandler PR; Manlapat A; Bingaman A; Kahler DJ; Munn DH; Mellor AL
Int Immunol; 2005 Jul; 17(7):909-19. PubMed ID: 15967784
[TBL] [Abstract][Full Text] [Related]
8. Up-regulation of Fas and the costimulatory molecules B7-1 and B7-2 on peripheral lymphocytes in autoimmune B6/gld mice.
Weintraub JP; Eisenberg RA; Cohen PL
J Immunol; 1997 Oct; 159(8):4117-26. PubMed ID: 9379003
[TBL] [Abstract][Full Text] [Related]
9. Expression of complement receptors 1 (CR1/CD35) and 2 (CR2/CD21), and co-signaling molecule CD19 in cattle.
Pringle ES; Firth MA; Chattha KS; Hodgins DC; Shewen PE
Dev Comp Immunol; 2012 Dec; 38(4):487-94. PubMed ID: 22989997
[TBL] [Abstract][Full Text] [Related]
10. Differential effects of the stimulation of complement receptors CR1 (CD35) and CR2 (CD21) on cell proliferation and intracellular Ca2+ mobilization of chronic lymphocytic leukemia B cells.
Hivroz C; Fischer E; Kazatchkine MD; Grillot-Courvalin C
J Immunol; 1991 Mar; 146(6):1766-72. PubMed ID: 1826011
[TBL] [Abstract][Full Text] [Related]
11. Complement receptors CD21 and CD35 in humoral immunity.
Roozendaal R; Carroll MC
Immunol Rev; 2007 Oct; 219():157-66. PubMed ID: 17850488
[TBL] [Abstract][Full Text] [Related]
12. Targeting antigen to CD19 on B cells efficiently activates T cells.
Yan J; Wolff MJ; Unternaehrer J; Mellman I; Mamula MJ
Int Immunol; 2005 Jul; 17(7):869-77. PubMed ID: 15967786
[TBL] [Abstract][Full Text] [Related]
13. Human complement receptor type 2 (CR2/CD21) transgenic mice provide an in vivo model to study immunoregulatory effects of receptor antagonists.
Kulik L; Chen K; Huber BT; Holers VM
Mol Immunol; 2011 Mar; 48(6-7):883-94. PubMed ID: 21269698
[TBL] [Abstract][Full Text] [Related]
14. Ligation of the functional domain of complement receptor type 2 (CR2, CD21) is relevant for complex formation in T cell lines.
Prodinger WM; Larcher C; Schwendinger M; Dierich MP
J Immunol; 1996 Apr; 156(7):2580-4. PubMed ID: 8786322
[TBL] [Abstract][Full Text] [Related]
15. Physiological up-regulation of inhibitory receptors Fc gamma RII and CR1 on memory B cells is lacking in SLE patients.
Isaák A; Gergely P; Szekeres Z; Prechl J; Poór G; Erdei A; Gergely J
Int Immunol; 2008 Feb; 20(2):185-92. PubMed ID: 18182380
[TBL] [Abstract][Full Text] [Related]
16. Induction of germinal center B cell markers in vitro by activated CD4+ T lymphocytes: the role of CD40 ligand, soluble factors, and B cell antigen receptor cross-linking.
Lahvis GP; Cerny J
J Immunol; 1997 Aug; 159(4):1783-93. PubMed ID: 9257841
[TBL] [Abstract][Full Text] [Related]
17. Differential up-regulation of the B7-1 and B7-2 costimulatory molecules after Ig receptor engagement by antigen.
Lenschow DJ; Sperling AI; Cooke MP; Freeman G; Rhee L; Decker DC; Gray G; Nadler LM; Goodnow CC; Bluestone JA
J Immunol; 1994 Sep; 153(5):1990-7. PubMed ID: 7519638
[TBL] [Abstract][Full Text] [Related]
18. Contribution of the innate immune system to autoimmune diabetes: a role for the CR1/CR2 complement receptors.
Noorchashm H; Moore DJ; Lieu YK; Noorchashm N; Schlachterman A; Song HK; Barker CF; Naji A
Cell Immunol; 1999 Jul; 195(1):75-9. PubMed ID: 10433799
[TBL] [Abstract][Full Text] [Related]
19. Melphalan-induced up-regulation of B7-1 surface expression on normal splenic B cells.
Donepudi M; Jovasevic VM; Raychaudhuri P; Mokyr MB
Cancer Immunol Immunother; 2003 Mar; 52(3):162-70. PubMed ID: 12649745
[TBL] [Abstract][Full Text] [Related]
20. Tissue-specific up-regulation of B7-1 expression and function during the course of murine relapsing experimental autoimmune encephalomyelitis.
Karandikar NJ; Vanderlugt CL; Eagar T; Tan L; Bluestone JA; Miller SD
J Immunol; 1998 Jul; 161(1):192-9. PubMed ID: 9647224
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
